Eltrombopag (25mg)
Revolade 25 mg Tablet is used for low platelet count due to ITP or HCV infection. It is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It’s also used to treat severe aplastic anemia.
1 Strip of 7 Tablet
Glaxo SmithKline Pharmaceuticals Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Revolade 25 mg Tablet is to be taken empty stomach.
Revolade 25 mg Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Revolade 25 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Revolade 25 mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well.
Revolade 25 mg Tablet can make you dizzy and have other side effects that make you less alert. This may affect your driving ability.
Revolade 25 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Revolade 25 mg Tablet is recommended.
However, inform your doctor if you have a kidney disease. Regular monitoring of kidney function tests may is advisable while you are taking this medicine.
Revolade 25 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Revolade 25 mg Tablet may be needed. Please consult your doctor.
